8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
People assigned to a diet, food or program and measured.
2013 / Multicenter randomized controlled trial
Over 18 weeks, corporate employees randomized to a low-fat vegan diet experienced greater reductions in body weight (-2.9 kg vs -0.06 kg, P < 0.001) and glycated hemoglobin (-0.6 vs -0.08 percentage points, P < 0.01) than controls. Total cholesterol dropped 8.0 mg/dl versus 0.01 mg/dl, and LDL cholesterol decreased 8.1 mg/dl versus 0.9 mg/dl (P < 0.01).
Mishra S, Xu J, Agarwal U, et al. Eur J Clin Nutr, 2013. PMID 23695207
2013 / Randomized controlled trial
Thirty-two obese participants were randomized to an alternate-day fasting (ADF) high-fat (45% fat) or low-fat (25% fat) diet for an 8-week weight-loss period following a 2-week baseline. Body weight decreased significantly in both ADF-HF (4.4±1.0 kg) and ADF-LF (3.7±0.7 kg) groups, while blood pressure remained unchanged. FMD decreased in the ADF-HF group (from 7±1 to 5±2%, P<0.05) but increased in the ADF-LF group (from 5±1 to 7±2%, P<0.05). Both diets increased adiponectin and decreased leptin and resistin, with adiponectin increases correlating with higher FMD only in the ADF-LF group (r=0.34, P=0.03).
Klempel MC, Kroeger CM, Norkeviciute E, et al. Nutr Diabetes, 2013. PMID 23712283
2013 / Randomized cross-over study
Twelve overweight/obese participants consumed two 3-week full-fat dairy diets (fermented: yogurt plus cheese; non-fermented: butter, cream, ice cream) or a low-fat dairy diet (milk plus yogurt) in a randomized cross-over design. Concentrations of six of eight CVD biomarkers tended to be higher on the low-fat diet compared to the fermented full-fat diet, and two plasmalogen lipid classes were significantly higher on the low-fat diet (P < 0.001). Plasma F2-isoprostane concentrations did not differ among diets, while plasma sphingomyelin and IL-6 were significantly higher after the non-fermented full-fat diet than the low-fat diet (P < 0.02).
Nestel PJ, Mellett N, Pally S, et al. Br J Nutr, 2013. PMID 23756569
2013 / Randomized controlled trial
A randomized trial assigned 5,145 overweight or obese adults with type 2 diabetes to an intensive lifestyle intervention focused on weight loss or to diabetes education. Over a median follow-up of 9.6 years, weight loss was greater in the lifestyle group (6.0% vs. 3.5% at study end). However, the primary cardiovascular composite endpoint did not differ significantly between groups (hazard ratio, 0.95; 95% CI, 0.83 to 1.09; P=0.51).
Look AHEAD Research Group, Wing RR, Bolin P, et al. N Engl J Med, 2013. PMID 23796131
2013 / Randomized crossover trial
Seventy healthy, normal-weight adults underwent three 9-hour interventions: prolonged sitting, continuous physical activity (30 min walking then sitting), and regular activity breaks (walking 1 min 40 s every 30 min), with meal-replacement drinks given at 60, 240, and 420 minutes. Regular activity breaks lowered plasma glucose iAUC by 18.9 mmol · L(-1) · 9 h(-1) compared with prolonged sitting and by 17.4 mmol · L(-1) · 9 h(-1) compared with continuous physical activity (both P < 0.001). Breaks also reduced insulin iAUC significantly more than prolonged sitting and continuous activity. Conversely, continuous physical activity lowered plasma triglyceride iAUC by 6.3 mmol · L(-1) · 9 h(-1) compared with regular activity breaks (P = 0.006).
Peddie MC, Bone JL, Rehrer NJ, et al. Am J Clin Nutr, 2013. PMID 23803893
2013 / Randomized crossover trial
Ten healthy subjects completed a randomized crossover trial testing four serving sizes of Brazil nuts (0, 5, 20, or 50 g), with blood drawn before and at multiple intervals up to 30 days. Plasma selenium levels significantly increased at 6 hours in groups receiving the nuts. Serum LDL-c was significantly lower and HDL-c was significantly higher 9 hours following the ingestion of 20 or 50 g of nuts. Biochemical markers of liver and kidney function were not modified.
Colpo E, Vilanova CD, Brenner Reetz LG, et al. J Nutr Metab, 2013. PMID 23840948
2013 / Secondary analysis of a randomized controlled trial
An analysis of 7,216 participants in the PREDIMED trial evaluated nut intake over a median follow-up of 4.8 years. Compared with non-consumers, individuals consuming more than three servings of nuts weekly had a 39% lower risk of total mortality (HR 0.61; 95% CI 0.45 to 0.83). Nut consumption was also linked to reduced risk of cardiovascular and cancer death, with the lowest overall mortality observed among nut group participants consuming this amount.
Guasch-Ferré M, Bulló M, Martínez-González MÁ, et al. BMC Med, 2013. PMID 23866098
2013 / Randomized controlled trial
Twenty-seven inactive older men underwent eight weeks of exercise training combined with 250 mg daily trans-resveratrol or placebo. Exercise raised maximal oxygen uptake 45% more in the placebo group than the resveratrol group (P < 0.05) and lowered mean arterial pressure only with placebo (-4.8 ± 1.7 mmHg, P < 0.05). Resveratrol also blunted exercise-related improvements in blood triglycerides and low-density lipoprotein, while Sirtuin 1 protein levels remained unaffected.
Gliemann L, Schmidt JF, Olesen J, et al. J Physiol, 2013. PMID 23878368
2013 / Randomized crossover trial
In a randomized crossover trial with 23 healthy men, eating 200 g of bread enriched with 100 g beetroot produced greater postprandial endothelium-independent microvascular vasodilation (P = 0.017) and lower diastolic blood pressure (P = 0.032) across six hours compared to white bread. Systolic blood pressure did not differ (P = 0.99). Plasma and urinary nitrate (P < 0.0001) and nitrite (P < 0.001) both increased significantly.
Hobbs DA, Goulding MG, Nguyen A, et al. J Nutr, 2013. PMID 23884387
2013 / Parallel trial
Fourteen healthy men who regularly skipped breakfast were assigned to an early mealtime group (eating at 8:00, 13:00, and 18:00; n=8) or a control group (eating at 13:00, 18:00, and 23:00; n=6) for 2 weeks. Compared to controls, triglyceride, total cholesterol, and LDL cholesterol levels significantly decreased in the early mealtime group (p = 0.035, 0.008, and 0.004, respectively). Acrophases for HRV variables were advanced in the early mealtime group, with significant pre-to-post intervention differences in LF power (-3.2 ± 1.2 h) and %HF (-1.2 ± 0.5 h) (p < 0.05).
Yoshizaki T, Tada Y, Hida A, et al. Eur J Appl Physiol, 2013. PMID 23922171
2013 / Randomized, double-blind, controlled trial
Eighty patients with type 2 diabetes were randomized to receive P. emblica extract (250 mg or 500 mg twice daily), atorvastatin (10 mg daily), or placebo for 12 weeks. P. emblica at 250 mg, 500 mg, and atorvastatin significantly decreased the reflection index (-2.25%±1.37% to -9.13%±2.56%, -2.11%±0.98% to -10.04%±0.92%, and -2.68%±1.13% to -11.03%±3.93%, respectively), indicating improved endothelial function. Biomarkers of oxidative stress, systemic inflammation, lipid profile, and HbA1c levels also significantly improved compared with baseline and placebo. All treatments were reported as well tolerated without significant changes in laboratory safety parameters.
Usharani P, Fatima N, Muralidhar N Diabetes Metab Syndr Obes, 2013. PMID 23935377
2013 / Open clinical trial with blinded Doppler examiners
An open clinical trial evaluated the effect of restricting polyphenol-rich foods (<30 mg/100 mg) for at least 2 weeks in 46 third-trimester fetuses compared to 26 controls. Maternal polyphenol intake fell from 1277 mg to 126 mg (p=0.0001) in the intervention group. In this group, systolic ductal velocity decreased from 1.2 ± 0.4 to 0.9 ± 0.3 m/s (p=0.018), diastolic velocity decreased from 0.21 ± 0.09 to 0.18 ± 0.06 m/s (p=0.016), RV/LV ratio decreased from 1.3 ± 0.2 to 1.1 ± 0.2 (p=0.004), and ductal PI increased from 2.2 ± 0.03 to 2.4 ± 0.4 (p=0.04). No significant changes were observed in the control group.
Zielinsky P, Piccoli AL, Vian I, et al. Arq Bras Cardiol, 2013. PMID 23949325
2013 / Randomized controlled trial
Subjects were randomly assigned to consume 400 g standard broccoli, 400 g high-glucoraphanin (HG) broccoli, or 400 g peas each week for 12 weeks. No significant differences in the effects of the diets on biomarkers of CVD risk were detected. However, univariate analysis showed significant effects of sex (P < 0.001), PAPOLG genotype (P < 0.001), and PAPOLG genotype × diet (P < 0.001) on plasma metabolic profiles. In the HG broccoli arm, the intervention reduced variation between the two PAPOLG genotypes in lipid and amino acid metabolites, tricarboxylic acid (TCA) cycle intermediates, and acylcarnitines.
Armah CN, Traka MH, Dainty JR, et al. Am J Clin Nutr, 2013. PMID 23964055
2013 / Randomized controlled crossover trial
Healthy men consumed drinks containing varying amounts of blueberry polyphenols or a polyphenol-free control. Ingestion induced a biphasic increase in flow-mediated dilation at 1 to 2 hours and 6 hours. At one hour post-consumption, flow-mediated dilation improved in a dose-dependent pattern up to 766 mg of polyphenols, reaching a plateau at higher doses.
Rodriguez-Mateos A, Rendeiro C, Bergillos-Meca T, et al. Am J Clin Nutr, 2013. PMID 24004888
2013 / Randomized crossover trial
In a randomized crossover trial, 76 participants consumed 25 g/d of blue lupin, white lupin, or soya fibre, compared with citrus fibre, for two weeks each. Supplementation with lupin fibres increased fecal dry matter and weight, enhanced short-chain fatty acids, and all legume fibres reduced fecal total and secondary bile acids by 16% to 24%. Blood lipids were not influenced by any of the fiber interventions.
Fechner A, Fenske K, Jahreis G Nutr J, 2013. PMID 24060277
2013 / Intervention study (before-and-after)
Twenty-six individuals with peripheral artery disease consumed 1/2 cup per day of cooked non-soy legumes (beans, peas, lentils, chickpeas) for 8 weeks. Total and LDL-cholesterol decreased by 5.0% and 8.7%, respectively, and ankle-brachial index (ABI) increased by 5.5%, though changes in ABI and LDL-cholesterol did not correlate. Serum markers of endothelial dysfunction and inflammation remained unchanged, but short-chain acylcarnitines significantly decreased.
Zahradka P, Wright B, Weighell W, et al. Atherosclerosis, 2013. PMID 24075762
2013 / Randomized controlled trial
In a 1-year PREDIMED sub-cohort trial of 169 high-cardiovascular-risk participants, a nut-supplemented Mediterranean diet decreased waist circumference (-5 cm; 95% CI: -7, -3) and total LDL particle concentration (-98 nmol/l; 95% CI: -184, -11). It also reduced small LDL subsets and expanded large LDL particles. Relative to other groups, nut supplementation significantly reduced waist circumference and increased average LDL diameter.
NANO counterpoint →
Damasceno NR, Sala-Vila A, Cofán M, et al. Atherosclerosis, 2013. PMID 24075767
2013 / Intervention trial
Six obese subjects with type 2 diabetes and/or hypertension were placed on a strict vegetarian diet for 1 month. The diet reduced body weight, triglycerides, total cholesterol, low-density lipoprotein cholesterol, and haemoglobin A1c, while improving fasting and postprandial glucose levels. It also reduced the Firmicutes-to-Bacteroidetes ratio, decreased pathobionts such as Enterobacteriaceae, increased commensals including Bacteroides fragilis and Clostridium species (clusters XIVa and IV), and lowered intestinal lipocalin-2 and short-chain fatty acid levels without altering enterotypes.
Kim MS, Hwang SS, Park EJ, et al. Environ Microbiol Rep, 2013. PMID 24115628
2013 / Randomized crossover trial
Twenty-six healthy participants aged 38 to 69 completed a randomized crossover trial comparing a meal providing 220 mg nitrate from spinach to a low-nitrate control. The spinach meal produced a higher large artery elasticity index (P < 0.001) as well as lower pulse pressure (P < 0.001) and systolic blood pressure (P < 0.001) up to 210 minutes postprandially. Carotid-femoral pulse wave velocity, augmentation index, and diastolic blood pressure did not differ significantly.
Liu AH, Bondonno CP, Croft KD, et al. Nitric Oxide, 2013. PMID 24120618
2013 / Prospective, double-blinded, placebo-controlled, randomized trial
In a prospective, double-blinded, placebo-controlled trial, 110 patients with peripheral artery disease ingested foods containing 30 g of milled flaxseed or placebo daily for 6 months. Plasma α-linolenic acid and enterolignans increased 2- to 50-fold in the flaxseed group, with no significant differences in body weight between groups. After 6 months, SBP was ≈ 10 mm Hg lower and DBP was ≈ 7 mm Hg lower in the flaxseed group compared with placebo. In participants with baseline SBP ≥ 140 mm Hg, flaxseed led to a reduction of 15 mm Hg in SBP and 7 mm Hg in DBP, showing selective antihypertensive effects in hypertensive patients.
Rodriguez-Leyva D, Weighell W, Edel AL, et al. Hypertension, 2013. PMID 24126178
2013 / Randomized controlled trial
In a 12-week trial, 32 normal-weight and overweight adults were assigned to alternate day fasting or a control group. Alternate day fasting reduced body weight by 5.2 ± 0.9 kg and fat mass by 3.6 ± 0.7 kg relative to controls (both P < 0.001). The fasting group also experienced decreases in triacylglycerols (-20 ± 8%) and CRP (-13 ± 17%), while LDL cholesterol, HDL cholesterol, and resistin remained unchanged.
Varady KA, Bhutani S, Klempel MC, et al. Nutr J, 2013. PMID 24215592
2013 / Intervention trial with crossover/washout
Sixty healthy volunteers aged 18-57 years consumed coconut milk porridge (CMP) for 5 days per week for 8 weeks, underwent a 2-week washout, and then consumed isoenergetic soya milk porridge (SMP) for 8 weeks. LDL levels decreased with CMP, reaching statistical significance across the total population and in those with baseline LDL >130. In addition, HDL levels rose significantly following CMP supplementation (P = 0.000). The authors concluded that coconut milk did not negatively affect lipid profiles and that SMP benefits individuals with elevated baseline LDL.
Ekanayaka RA, Ekanayaka NK, Perera B, et al. J Nutr Metab, 2013. PMID 24282632
2013 / Interventional crossover trial
Ten healthy men were evaluated before and 4 hours after consuming a high-fat meal, tested either with or without approximately 50 minutes of endurance exercise (70% VO2 max) performed on the previous day. The high-fat meal resulted in lower leptin and higher VEGF, bFGF, IL-6, and IL-8 concentrations (P < 0.05 for all), with no effect on PlGF, TNF-α, or RBP4. Prior exercise was associated with lower leptin concentrations (P < 0.05) and an interactive effect on sFlt-1 (P < 0.05). Furthermore, the high-fat meal increased IL-6 by 59% without prior exercise and by 218% with prior exercise (P < 0.05).
Brandauer J, Landers-Ramos RQ, Jenkins NT, et al. Physiol Rep, 2013. PMID 24303126
2013 / Interventional study
Thirty female subjects with or without metabolic syndrome underwent a 7-day Buchinger modified fast providing 300 kcal/day. Mean weight decreased from 85.4 ± 18.8 kg to 79.7 ± 18.2 kg, with systolic and diastolic blood pressure reductions of -16.2 mm Hg (95% CI: -9.1; -23.3 mm Hg, p < 0.001) and -6.0 mm Hg (95% CI: -1.8; -10.3 mm Hg, p = 0.005). Fasting also decreased LDL-cholesterol, leptin, and insulin, increased adiponectin, leptin receptors, and resistin, and improved mood scores (decreased anxiety, depression, fatigue, and improved vigor).
Li C, Ostermann T, Hardt M, et al. Forsch Komplementmed, 2013. PMID 24434755